UNIVERSAL HEALTH SERVICES-B (UHS) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:UHS - US9139031002 - Common Stock
243.29 USD
-0.89 (-0.36%)
ChartMill assigns a Buy % Consensus number of 71% to UHS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 249.24. This target is 2.45% above the current price.
UHS was analyzed by 26 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about UHS.
In the previous month the buy percentage consensus was at a similar level.
UHS was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-30 | RBC Capital | Maintains | Sector Perform -> Sector Performer |
| 2025-10-29 | Cantor Fitzgerald | Maintains | Neutral -> Neutral |
| 2025-10-29 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-29 | UBS | Maintains | Buy -> Buy |
| 2025-10-28 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-07 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-10-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-18 | Barclays | Maintains | Overweight -> Overweight |
| 2025-08-26 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-08-19 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-08-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-14 | Baird | Maintains | Neutral -> Neutral |
| 2025-08-04 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-07-30 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-16 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2025-04-30 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-04-29 | Barclays | Maintains | Overweight -> Overweight |
| 2025-04-15 | Baird | Downgrade | Outperform -> Neutral |
| 2025-04-09 | Guggenheim | Initiate | Buy |
| 2025-03-26 | Morgan Stanley | Initiate | Equal-Weight |
| 2025-03-10 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-02-28 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-27 | Stephens & Co. | Reiterate | Equal-Weight -> Equal-Weight |
| 2025-02-27 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-26 | TD Cowen | Maintains | Buy -> Buy |
| 2024-11-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-11-06 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-10-28 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-28 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
UNIVERSAL HEALTH SERVICES-B / UHS FAQ
What is the price target for UHS stock?
26 analysts have analysed UHS and the average price target is 249.24 USD. This implies a price increase of 2.45% is expected in the next year compared to the current price of 243.29.
What is the consensus rating for UHS stock?
The consensus rating for UNIVERSAL HEALTH SERVICES-B (UHS) is 70.7692 / 100 . This indicates that analysts generally have a positive outlook on the stock.